8 March 2017 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Background:Patients with arterial perinatal stroke often suffer long-term motor sequelae, difficulties in language, social development, and behaviour as well as epilepsy. Despite homogeneous lesions, long-term behavioural and cognitive outcomes are variable and unpredictable. Sleep-related epileptic encephalopathies can occur after early brain injury and are associated with global developmental delays. We hypothesized that sleep-potentiated epileptiform abnormalities are associated with worse developmental outcomes after perinatal stroke.Methods:Participants were identified from a population-based cohort (Alberta Perinatal Stroke Project). Inclusion criteria were magnetic resonance imaging–confirmed arterial perinatal stroke, age 4 to 18 years, electroencephalogram (EEG) including sleep, and comprehensive neuropsychological evaluation. Sleep-related EEG abnormalities were categorized by an epileptologist blinded to the cognitive outcome. Associations between EEG classification and neuropsychological outcomes were explored (ttests, Bonferroni correction for multiple comparisons).Results:Of 128 potentially eligible participants, 34 (53% female) had complete EEG (mean age, 8.1 years; range, 0.2-16.4) and neuropsychology testing (mean age, 9.8 years; range 4.4-16.7). Twelve (35%) were classified as having electrical status epilepticus in sleep. Patients with abnormal EEGs were more likely to have statistically worse scores when corrected for multiple comparisons, in receptive language (median, 1st percentile; IQR 1-7th percentile; p<0.05), and externalizing behaviours (median, 82nd percentile; IQR, 79-97th percentile; p<0.05).Conclusions:Developmental outcome in language and behaviour in children with arterial perinatal stroke is associated with electrical status epilepticus in sleep. Increased screening with sleep EEG is suggested, whereas further studies are necessary to determine if treatment of EEG abnormalities can improve outcome.
23 September 2023 in Medical Science Educator
4 January 2026 in Medical Teacher
Factors influencing successful remediation in postgraduate medical education remain largely unexplored. This study aims to investigate the variables associated with remediation outcomes. This was a retrospective cohort study of all residents who underwent remediation from July 1, 2012 - June 30, 2024 at the University of Calgary Cumming School of Medicine Postgraduate Medical Education. Multilevel mixed-effects logistic regression was used to identify outcome variables associated with remediation success. The most common CanMEDS roles remediated were Professional (52.7%), Communicator (51.1%), and Medical Expert (45.1%). Reduced odds of successful remediation were seen when the remediation plan included the Medical Expert Role (Odds Ratio (OR) 0.35 [0.14, 0.82], p = 0.016); and an increasing number of successful prior remediations (OR 0.58 [0.35, 0.95], p = 0.029). Remediation rates in postgraduate medical education are rising. Difficulties in the Medical Expert role are associated with lower remediation success and persistent issues that lead to recurrent remediations predict poor outcomes. Support should target core competencies, provide compassionate exit strategies for recurring struggles, and prioritize early intervention research.
28 February 2026 in Developmental Medicine & Child Neurology
This commentary is on the original article by Springer et al. on pages 1237–1245 of this issue.
19 June 2026 in European Journal of Haematology
Background: Sickle cell disease (SCD) is a chronic and life‐limiting hemoglobin and systemic vascular disease. While over 1000 people have undergone hematopoietic cell transplantation (HCT) over the last 40 years, long‐term disease‐specific and health‐related quality of life data are lacking. The American Society of Hematology 2021 Guidelines for SCD emphasized the need for more detailed registry data to inform patients and providers with decision‐making and practice recommendations. Procedures: In January 2021, the Sickle Cell Transplant Advocacy and Research Alliance (STAR) launched Project Sickle Cure (PSC). This multi‐center, prospective study of patients who have undergone HCT for SCD includes baseline demographics and SCD‐specific post‐HCT outcomes, serial neurocognitive testing, health‐related quality of life measures, health equity evaluations, a neuroimaging bank, detailed evaluation of neurologic status pre‐ and post‐transplant, and chronic pain evaluation. A biorepository is in the planning stage of development. Results: As of November 2025, 115 participants have enrolled at 18 STAR sites with enrollment ongoing. Conclusions: PSC is a STAR prospective study which will address a major gap in our understanding of outcomes post‐HCT specific to SCD. WeDecide, a larger study comparing HCT health‐related quality of life outcomes to those who receive non‐transplant disease modifying therapy (NT‐DMT) is in development, and PSC will provide the HCT comparator data. These data will also be highly relevant as other curative and transformative therapies, such as gene therapy, become more widely used.
24 September 2021 in Journal of Child Neurology